Keith Loo (00:00)
you have people younger than me tell our team that they're planning their funerals because they've been waiting too long because of skin cancer, which just sounds ridiculous, right? And so you hear this long enough and like we really weren't trying to build a company. We wanted just to help people like her and the many others that we saw through Dr. Hong's clinic. So it would be a little fuzzy to come back to say, know, when did we really become a company?
versus when were we just a tool that we wanted to hand out for free? And are tools available for free for anyone to download? So you can go on the app store, look for GetSkinHelp, you can download it. It's a skin cancer screening tool. Which won innovation first prize by the Canadian Society of Plastic is clinically valid. This is not just chat GPT trying to take pictures of you. trust this.
Jim Wilson (00:51)
Welcome to NGBiLab a podcast about innovators and disruptors who are creating the next generation of companies in Canadian life sciences.
Jim Wilson (01:05)
I'm Jim Wilson, and my guest today is Keith Loo who is the co-founder and CEO of Skinopathy in Toronto, Ontario. The mission at Skinopathy is to provide accessible healthcare on demand. It's a story that you will be interested in hearing because it touches on the next generation of healthcare. Keith has spent more than 20 years working in the technology sector with the likes of Logitech,
IBM and Microsoft, but during the pandemic a conversation Keith had with a friend who is a reconstructive surgeon made him aware of a growing problem, which was that patients with skin cancer were waiting months and sometimes years to see a specialist.
Jim Wilson (01:49)
That conversation led to the creation of Skinopathy, which is a company that uses artificial intelligence and smartphone technology to help patients screen skin conditions earlier and connect with physicians faster. In our conversation, Keith talks about how Skinopathy came together, how the technology works, and what it takes to build a company at the intersection of healthcare, artificial intelligence, and patient access.
Jim Wilson (02:18)
Before we get to our conversation, we'd like to let you know this podcast is one of the NGBi podcasts which we produce to promote next great big ideas, Canada's Life Sciences Summit. NGBi is an annual national networking event for Canada's life sciences community and an independently organized not-for-profit fundraising event in support of McMaster Children's Hospital. For details on the NGBi Summit, please go to next.
greatbigideas.com. This episode of NGBILab was recorded in January 2025.
Jim Wilson (02:56)
Skinopathy, think, if you haven't heard about this company, cool and it's based here in Toronto. And our guest today is one of the co-founders, Keith Loo Keith, welcome to NGBi Labs.
Keith Loo (03:06)
Thank you for having me.
Jim Wilson (03:07)
it's a pleasure. I'm really looking forward to this. I am so fascinated by what you and your team are doing. What is the problem that you're trying to solve?
Keith Loo (03:16)
You know, we weren't trying to build a company, first of all, my co founders, a and reconstructive surgeon. And during the pandemic, he was seeing that more and more people were coming into his clinic with late stage skin cancer. And he just figured that we needed to get ahead of this or else we're gonna have a pandemic of people dying from skin cancer. And that's really kind of how we started was just trying to help people get skin cancer treatment faster.
Jim Wilson (03:38)
And so this was a friend of yours who just came to you one day, you're what, shooting pool and saying, Hey, I got to talk to somebody about this. What do think?
Keith Loo (03:46)
That's right. Yeah, we were just having a conversation about this, I believe in in his kitchen. And we just need to solve for this because we were literally seeing patients with golf ball size growth on their necks and their groins and leading them to you know, having to go through chemo like it just went really far because people were waiting 1218 months to get surgery, right. And that was just becoming a bigger and bigger problem.
Jim Wilson (04:10)
So the company was founded almost five years ago in August of 2020 by you and Colin. guess the idea really did spring out pandemic, so to speak, in an oblique way. had a heck of a trajectory. You've been riding a rocket ship since then.
Keith Loo (04:31)
Yeah, it's been going pretty well. Yes.
Jim Wilson (04:33)
So like in December, so you found it in August and then in December that year you launched Get Skin Help, which if I understand correctly is a website that connects to doctors with patients to have their skin concerns addressed, is that right?
Keith Loo (04:47)
That's right. it's not even, just a website. It's an actual medical clinic that serves in person and virtual. And we have apps for you to download. And so the original premise was we just wanted to give our patients an app for them to screen for skin cancer at home. That was it. And it, it sounded not like rocket science. mean, you know, CNNs are a solved problem. This has been around forever. And there were hundreds of companies that claimed that they could do it. However,
when we did our deep dive, it turned out that none of the technologies that existed could be used in a medical setting practically. So let me tell you why. So first, there's a lot of technologies that work and they work amazingly well. However, they typically require our patients to go and buy a specialized camera. So imagine like a like a super magnifying glass, like a derma scope, but these cameras could cost hundreds to maybe $1,000. And it
It's unreasonable to ask anyone to go and spend $500 on a camera to take a picture of a random bump on their skin. Right? Like think about just really think about in a practical setting. didn't make sense. And secondly, there's a lot of really cool tech out of Silicon Valley, And out of, you know, tech companies, and we have a joke, this is, know, we myself and tech bros love creating tech, but it's not very practically used in medicine. Like it's, it's built by really smart engineers.
who don't necessarily understand healthcare. And so if we're adding more steps to the health protocol or the medical protocol, it just won't be used. And the last part is none of it's approved anyway. And to use this type of technology in a medical setting, it has to be approved, right? By Health Canada and FDA, And the last part was that any technology that did work would work for someone like you and me. We're relatively fair skinned.
But there's no technology in the world that actually worked for darker skinned individuals. And we live in Canada, we have a mosaic of a population, a fair amount of people who have darker skin. so that was a major challenge. And so we needed to build our own and that's what.
Jim Wilson (06:45)
So do people just take out their cell phone, take an image and email it to you?
Keith Loo (06:51)
They don't have to email it to us. They take a picture with their cell phone with our app. Immediately we will give them an analysis to say, is it likely one of three conditions that we might believe it is? And we'll tell you roughly how urgent it is to go take care of it. And now you have the option, at least you have an analysis. You can now take this to your family doctor or if you have a dermatologist or a plastic surgeon that you work with.
But most people in Canada have a problem with getting to their doctor. And so if you cannot get to your doctor very quickly, we will connect you with a doctor on our platform who will help you with it. And so let me just give you context in Canada in 2024, the average wait time from referral to treatment of any condition was over 30 weeks. So anything that you had to any specialist anywhere in Canada, but that's the average.
we humans tend to think of skin as say less important than let's say the heart, right? When it comes to skin, it actually goes longer. So we live in the GTHA. Here, we complain about waiting for three to six months, right? However, we've had patients in Ottawa who've had to wait over 18 months with late stage cancer.
We've had patients and we've had doctors in Northern Ontario tell us that their wait times are over two years to get to a skin referral. And then we've worked with doctors who've told us in Nova Scotia and Saskatchewan, the wait times are up to 36 months. it's crazy, right? So if you think about it, if we had a child who had a rash and they had to wait that long, that would be incredibly stressful for the child and for us as parents.
But we had a teenager with a moderate to severe acne that could really change their life if that you had to live with that for a long time. But if you have skin cancer, that might kill you. And so that's why we had to do this.
Jim Wilson (08:40)
So there's your why. And so you literally take a picture with your cell phone. It's immediately transferred by the app to you folks. is it an AI algorithm that helps determine what this is? Or like, it's not somebody going, yeah, I think it's stinking.
Keith Loo (08:57)
So yes, it is an AI algorithm. So we developed and created this ourselves and just started in 2020. And still the world's only third generation dermatological AI that can screen track and manage any skin condition on any skin color on any camera with clinical relevance. So it works.
on any condition. So we started with skin cancer, but now our technology is used for a variety of different skin conditions. It actually is the only technology also that works on any skin color clinically. So dark skin for the first time, we can help people assess their redness on black skin, for example. And it works on my mom's iPhone 6 without additional hardware. a lot of our algorithms are actually more accurate than doctors. And it's used in hospitals, clinics, and long-term care facilities.
Wow.
Jim Wilson (09:45)
So this idea goes from a casual conversation with your friend Colin in your house to a boardroom setting, how quickly? Like from the idea of, you know, here's the problem. You know what, let's tackle this. When did it become, how long did it to become a business?
Keith Loo (10:06)
That's a good question. I think it's kind of fuzzy even for us because you can ask Dr. Hong, us starting a business really wasn't on our mind. Like we were in a situation where people really needed help. look at that first year, I can't tell you how many times I cried because I'm not from healthcare. I'm in tech my entire career. And so meeting patients, we have stories on our website and some of them go live and record their stories.
that you have people younger than me tell our team that they're planning their funerals because they've been waiting too long because of skin cancer, which just sounds ridiculous, right? And so you hear this long enough and like we really weren't trying to build a company. We wanted just to help people like her and the many others that we saw through Dr. Hong's clinic. So it would be a little fuzzy to come back to say, know, when did we really become a company?
versus when were we just a tool that we wanted to hand out for free? And are tools available for free for anyone to download? So you can go on the app store, look for GetSkinHelp, you can download it. It's a skin cancer screening tool. Which won innovation first prize by the Canadian Society of Plastic is clinically valid. This is not just chat GPT trying to take pictures of you. trust this.
Jim Wilson (11:21)
it's Jim. When we come back, Keith explains how a conversation during the pandemic turned into an idea for a company and how his background in the technology sector helped identify where it should focus. Stay with us. I'm Jim Wilson and you're listening to NGBILab, Canada's life sciences startup podcast.
Jim Wilson (11:44)
If you're not aware, the goal of this show and our other podcasts is to promote Next Great Big Ideas, Canada's Life Sciences Summit. NGBi is an annual national networking event for Canada's life sciences community, and we invite you to join us. For details, please go to nextgreatbigideas.com. Now, on that note,
If you would like to become a sponsor of the summit or this podcast, please send us an email. My contact information is at the end of today's show and we look forward to hearing from you. Thanks so much for your interest. Let's get back to our conversation.
Jim Wilson (12:22)
Hey, welcome back. It's Jim Wilson and my guest today is Keith Lu of Skinopathy in Toronto, Ontario.
Jim Wilson (12:32)
you mentioned you were in tech before this. What were you doing?
Keith Loo (12:36)
I've done a lot of things in tech. It's been 20 something years now and I've had the privilege of working with companies like IBM, Logitech, Apple, Microsoft, other companies, but usually the business of tech is where I resided. And my most recent enterprise role when I was at Microsoft, helping them with their open source software business.
So think about the free software. Most people are not familiar with open source software, but it was really cool to be there at the genesis of Microsoft and their open source software and now being one of the biggest businesses in the company.
Jim Wilson (13:10)
So serendipity brought you together and this idea landed in your lap, so to speak. So let's go back to the business. In February of 2021, you filed your first patent around a proprietary artificial intelligence technology that, as you explained, analyzes pictures of skin diseases. Your partnership since then, and this is just like four years ago,
You've partnered with a number of organizations, including the University of Alberta and Miele in Montreal, and I'd appreciate you taking a moment to explain why them.
Keith Loo (13:43)
That's a great question. So we'll start with University of Alberta. It was a really cool interaction that happened. there were a lot of companies that were working on solving for skin cancer, the feedback we heard from the burn unit from the University of Alberta was that there was no technology whatsoever for burn patients. Canada, the way we structure our hospitals is we have specific
burn units where for severe burns, that's where you would take your patients, we would send our patients and University of Alberta is one of those burn units. And what they've told us was that EMS is are typically not trained on burn assessment. And we also heard that firefighters are also not trained on burn assessment, their job is to fight the fire, right. And so however, these frontline, frontline individuals such as firefighters can often get burned.
And so could, of course, the actual patients on site. And it's very important if you think about it from a forest firefighting perspective, if someone gets burned right there, we have to make the decision. Do we send them to the burn unit? Do we send them to emergency or do we send them to say their family doctor just go home? And that assessment has very real consequences because if we decide to send them to a burn unit, they might have to take the helicopter. However,
If the next person needed the helicopter and that patient actually didn't, then now a patient suffers, right? The quality of life of that patient is really impacted. So by actually putting our technology on a cell phone that is validated for anyone to use to assess burn severity with your cell phone, it's a new capability that has not existed before. And so much so that last year the American Burns Association
gave us an award where we were able to show that our burn assessment was actually closer to the gold standard than doctors.
Jim Wilson (15:32)
that is still cool. I mentioned earlier, it's like reading about your companies, like watching a rocket take off. It's so impressive. Your trajectory from August 20 into 2021, you partnered with ICEDD, the Innovation, Science and Economic Development Canada folks to create this proof of concept which you can talk about. And in September of that year,
You your medical license from Health Canada and you just kept going. Where are you today?
Keith Loo (16:01)
That's a great question. So, you know, I started off by telling you the premise of the wait times in Canada, right? And I'll tell you, day one, when we started this, like we, I think we saw our first patient in December, like we literally incorporated the organization in late August of 2020. And in December, we saw our first patient. And as you can imagine, pandemic, everybody's locked down, we're trying to figure things out. But we were able to help our patients. Our Google average rating,
in 2020, 2021 was something like 2.7. The experience frankly, we were able to help people very proud of that. But you know, it's clunky, right? Like use this tool, use zoom, use all of this, and you have to do it in a compliant way. And we're very proud of the fact that our Google average in 2024, the average rating was 4.8. And which brought our cumulative average, I think through time to 4.3. So start at 2.7. We're at 4.3 now because our average is 4.8, which
tells us I think the experience is pretty good now. And that is because our average wait time at skin apathy for any skin condition is two weeks. However, if you're in the GTHA, and you have an urgent matter, such as you know, someone your family have a bad rash, a burn or something that's really bothering your child, anything that's deemed urgent, we have a rapid access clinic, probably get you seen within 24 hours.
and everyone in that rapid access clinic would be focused on skin. So that's the current state in terms of solving the original problem that we tried to solve. And I think we're doing okay with that, but what's interesting is since doing that, we have received a lot of global interest in our technologies and our capabilities. Like the core of what we do is our medical practices, physicians, nurses, administrators,
hyper efficient. If we can make them more efficient, they can deliver more and higher quality care to more people. So instead of doing all of their clerical burden, the doctor or nurse can focus on just getting to know the patient. How are you really feeling? And so that really improves the process and ultimately delivers better quality outcomes for the patient.
And so now this technology we're deploying into numerous clinics and potentially hospitals in Malaysia at this quarter. We just got off a partnership discussion out of a couple of African countries. I just came back from Tokyo where we had a lot of interest to deploy our technology in nursing homes and in different settings. And this past year, I think opened up 20 plus countries.
that have been interested in leveraging our technology. And that's just on the healthcare side. But what has been really exciting and something that everybody at Schenopathy is incredibly passionate about myself included is medical research. Medical research typically takes a lot of time, it's very costly, resource intensive. And we have an EMR system that is so smart in real time, real world data.
We're able to really accelerate medical research because of all the data we can gather through our patients who give us explicit consent to leverage their data to help other patients like them. And so as a young startup, we've been able to publish and podium and present 46 times, which from what I hear is a rather unique achievement for a young startup because we're not.
here as a company to publish, we're here to help people. It just so happened that we've been able to publish so much novel science. And then we commercialize that novel science really quickly, put it in the hands of our patients. And a lot of pharmaceuticals and manufacturers see this and now have asked us to collaborate with them to help accelerate their research.
Jim Wilson (19:42)
So I'm afraid to ask my next question. Where does Canada rank in the interest of the person shown in the company? Like, are you getting a buy-in from the hospitals here or are you having to go outside of the country to get that buy-in?
Keith Loo (19:59)
I'll say this. I think we're very fortunate really to get a lot of interest in what we do. In Canada, we have worked with a lot of institutions from the board down to the executive team down to the decision leads.
all incredibly passionate and wanting to use our technologies. However, the bureaucracy typically draws out that time for us to deploy. So it might take months or years for a clinic or hospital, more like a hospital, to really dive into our technology, even though the demanded interest was there since day one. And to give you a different context, when we're talking about other countries,
after the first meeting. They asked us to start. So it's it's just different.
Jim Wilson (20:44)
That's a polite way to put it. And I look forward to time that I walk into a doctor's office and see information on your company rather than a fax machine, which boggles my mind. So you've had a number of corporate, us, And one in particular caught my eye.
Walmart? What's with that?
Keith Loo (21:05)
You know, it was a really organic, again, relationship with Walmart. So here's the thing, we see a lot of patients, as you can imagine, our doctors see a lot of patients for a variety of skin conditions and hair loss, which happens on your skin. And the most common thing that we would do, one of the more common things we would do, we am not a doctor, our doctors would typically say, hey, you have hair loss, maybe one thing you should try is
go and buy some hair loss products. And one of them, a very popular one, is called Rogaine. And the most common place that people would go and potentially buy it is Walmart. So it just became a regular, hey, you want to buy some Rogaine? Go to Walmart, right? again, if we deal with skin, do you need a moisturizer? Do you need, Go to Walmart. It was a common occurrence. And so we reached out to Walmart and said, hey,
we're sending a lot of patients here, we're like, yeah, we noticed. And so how about they give us like a personalized offer for anyone that came through us. And again, there was a lot of interest in terms of, I can't talk too much about the other types of collaborations we're looking at. But in general, just a lot of synergy in terms of they provide a lot of products, retailers in general are very interested in personalized recommendations, right? What actually
do I need that you can provide me, not just what you have on sale? And we as an organization, we're data and AI centric. We know exactly what our patients need.
Jim Wilson (22:31)
wow, that makes sense. Thank you. I'd like to go back for a moment and talk about your original financing. When the company started, were you bootstrapped or did you have the friends and family see ground? did you get over that hurt?
Keith Loo (22:44)
good question. We're incredibly bootstrapped. Dr. Hong and I bootstrapped this company quite a bit. And then we'll call it friends and family who really supported us. Thankfully we have some friends and family who really believe in us and the amount of support that they put in you would never expect that. And we never asked for money to start because we don't
want to jeopardize anybody's investment. I've been in the startup world for a long time. There's no such thing as a guarantee. And so the last thing we want to do is go and, you know, jeopardize someone's hard earned money. So for the longest time, Dr. Hong and I just bootstrap this, just to make sure that you know, we can get this going. But then we receive a lot of interest from venture capital, and from corporate venture capital. And so we've brought on I think a couple of VCs.
for let's call it our seed round. And so, you we've had a mix. What we've found that has worked best for us is what we call super angels. And so angels who really believe in what we do can bring strategic value in terms of how we grow, right? Like it's your money is great. Of course, as a startup, we love money. But more importantly, can you help bring us somewhere?
so that we can help more people and help more organizations. And so those are the investors that we have really taken in in the past year. And they've just been phenomenal, like rolling up their sleeves and introducing us, getting involved in traveling with us, everything. It's been great. And I have to stress the different levels of Canadian agencies have been phenomenal support as well.
Jim Wilson (24:17)
it's Jim again. When we come back, Keith and I talk about the team behind Skinopathy and how the company has grown into an organization that is attracting global attention. I'm Jim Wilson, and you're listening to NGBILab. Don't go away. We'll be right back.
Jim Wilson (24:36)
Hi, it's Jim Wilson. I'd like to take a moment to explain the goal of this podcast is to shine a light on innovators and disruptors who are creating the next generation of companies in Canadian life sciences. We hope you enjoy learning about what ideas are on the horizon and learning who the people are behind those ideas. We also hope you like what we're doing and we have a small favour to ask. We will greatly appreciate you promoting us on social
with the hashtags NGBILab, NGBIPodcasts, and
Jim Wilson (25:10)
By the way if you're a startup founder who is working on one of the next great big ideas in Canadian life sciences Or you know someone who is please reach out to us My contact information is at the end of today's show and we look forward to hearing from you. Thanks so much Let's get back to our conversation
Jim Wilson (25:32)
That's good to hear. How many people are on your team?
Keith Loo (25:34)
That's a good question. That number kind of changes. It kind of grows. I think we're in full time, maybe in our thirties, I think part time, probably somewhere around there. And then we have, you know, dozens of physicians who work with us very regularly and our advisors. So it's, and we take on a lot of students because as you can imagine, there's a lot of interest in our world right now, AI, healthcare, medicine, engineering,
And so whether students are in engineering, health, healthcare, biotech, right? And everybody's interested in AI. So we get a lot of interest from pretty much all schools. And so we've taken on, think, close to 300 students to I teach university, I love helping students grow and helping young minds grow. And so if there are opportunities where we can collaborate with universities and colleges, which have been amazing for us, we do that.
Jim Wilson (26:25)
But we're only talking about a corporate journey that's not even five years on. And I'm wondering if during your journey today, have you ever had a moment where you thought, I don't know, we're going to get past this?
Keith Loo (26:38)
You know, we are going through a very interesting time. Our whole world is how AI is actually changing the world literally. You can see how the economic impact, but I think more importantly, how it impacts us as think all of us are hearing more more stories of people losing jobs or, worried about losing their jobs. There seems to be a layoff everywhere every other week.
I'm especially in tech companies too, right? And then there was a massive shift a couple of years ago when the Silicon Valley bank died, right? And that impacted the startup ecosystem, right? And so it's interesting. This is my incredibly long way of saying the thing that keeps me up at night is that we have 30 something families full time and a bunch of families part time that depend on us.
for their livelihood. That is the only thing that keeps me up at night. We don't have a concern whether or not we're going to help people. We know we will. We don't have a concern whether or not there's demand around the world. We know there is. But you know, no business is guaranteed. And that is the thing that we stress about. But there are times, like as a founder,
Am I going to make payroll is a very real question, right? And it's, it's different when you just have to worry about your own rent or your own mortgage, or your own family. It's a lot more when you have to consider the amount of impact that you have. And so I think, you know, neither now, I don't think there's not so much doubt is that that's the stress.
Jim Wilson (28:05)
comes with seeing well, you used to say the corner office, the person who likes to check. I've been there in previous life and I empathize with that you're in. Let's talk about a better or more topic. You and your team, we mentioned earlier, some of the awards you've won.
It's a laundry list of awards. And just last year, you won awards at AI Med24, Startup World, you recognized as a top 20 early tech company by the Canadian Innovation Exchange. And the list goes on and on and on. What is it that sets you and your team apart?
Keith Loo (28:28)
Yeah.
Yeah, honestly, it kind of blows our mind. You're right. We get a lot of awards we didn't apply for like often, right? Like they just announced and tell us that you've been nominated and you've won, which is kind of amazing. Like we don't set up these awards, if that makes sense. And
I think it's a combination of a few things. One, we're doing something that's important. I've had a very long career.
I feel like what I'm doing matters. I'm helping people, Fulfilled, right? And that I'm having an impact, whether it's one person or a hundred people or a million people. It's something I say to my team all the time. I really do mean this. Even if our company died tomorrow, I think we were all very proud of what we've been able to achieve in four years. And I absolutely do mean this.
And so one, think it's what we do matters. too, the technology and our approach to it is novel. And we're not just creating tech for tech sake, I've worked for tech companies where that was the case, right? Like if you, have a quarterly shareholders meeting, you just have to deliver new features and new products, right? So we're not ever delivering tech for tech sake. We're building technologies again, to make
the jobs of doctors easier and the lives of patients better, right? And that's all we focus on. And so the tech that we develop that's novel actually has very good use. And then finally, I guess it's just, you know, if you think about it from a business perspective, that's where you get these startup awards. Health is evergreen. And so it's the business has a very good potential. So you take all three of that together. and I can't forget.
We have a ridiculously good team. And so you put all of that together. I think that's what attracts others like us to come and join. yeah. Right? And then that's how you start getting attention in these awards.
Jim Wilson (30:28)
And I keep reading more and more about the accolades that are getting hate-dogged here on your team. For any budding entrepreneurs who may be listening to our conversation, is there any advice you would give to them that you wish someone had given to you, like, four or five years ago?
Keith Loo (30:44)
I think, you know, there's a lot of advice I teach at the Schulich School of Business and I teach entrepreneurship and so I have plenty of advice I can offer. But I think one is I think a lot of us have almost romanticized startups quite a bit to the point where I don't know what it is. I don't think there's many shows that feel this way, but it's like
I just have to have a great idea and I talked to Mark Cuban about it and he's going to write me a big fat check, right? And people are going to line up and give me checks. And so I just need a great idea and someone's going to pay me for it. It doesn't work that way, right? The vast majority of startups and entrepreneurs, it's their blood, sweat and tears that went into it. And for many months or many years did not get paid and no one supported them and everyone doubted them.
And it is through all of that grit and challenge, they were able to prove and validate that they were right and that they have a product market fit and that people want their product and people willing to buy it. And that's when people actually start funding your company. Right. It's gone are the days of I have a great idea and here's an idea on the back of a napkin and here's a whole bunch of money. You know, if you've built 20 startups before, maybe, but like if you're a budding entrepreneur,
Prove that you can do what you can do and prove that people want it. I think those are the most important steps in building a company, not just the idea.
Jim Wilson (32:05)
They don't buy what you do, they buy why you do it.
Keith Loo (32:09)
and how you do it.
Jim Wilson (32:09)
Yeah. I've got so many questions I'd love to ask, so I want to be respectful of your time. And thank you for joining us. This has been great from my perspective, learning more about a company that I think you've got to tag about. And I keep reading about the awards that you're winning. I'm sure there's many more to come. And thank you so much for your time.
Keith Loo (32:33)
Thank you, Jim. I really appreciate this opportunity. I have to stress, know, we as a startup, we don't have money for marketing. don't, like we don't do marketing. We focus all of our attention on taking care of our patients and supporting our partners to help them scale our technology. So this makes a big difference for a small company. So really appreciate it. Thank you for your time.
Jim Wilson (32:54)
It's the right kind of you to say.
Jim Wilson (32:59)
That was Keith Loo who is the co-founder and CEO of Skinopathy, which is a health tech company focused on improving access to care through AI-driven skin screening and clinical support tools. If you'd like to learn more about Skinopathy and the work they're doing, visit skinopathy.com. That's S-K-I-N-O-P-A-T-H-Y. You can also follow them on social at Skinopathy.
If you'd like to follow this show on social, we are at NGBIPodcasts, and you can learn more about the show at nextgreatbigideas.com. For details about who I am and what I do in my day job, visit jim-wilson.ca and laboccupier.com. You can also follow me on social at laboccupier. This episode was researched by Xenia Pinto and edited by noLMIT Marketing. If you'd like to get in touch, send us an email.
My address is jwilson at lennard.com. Thanks so much for listening. See you next time.